 | • レポートコード：MRC2-11QY07965 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はNADPHオキシダーゼ4のグローバル市場について調査・分析したレポートです。種類別（GKT-136901、GKT-831、MTfp-siRNA、その他）市場規模、用途別（虚血性脳卒中、腎臓病、肝線維症、腎臓線維症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別NADPHオキシダーゼ4の競争状況、市場シェア ・世界のNADPHオキシダーゼ4市場：種類別市場規模 2015年-2020年（GKT-136901、GKT-831、MTfp-siRNA、その他） ・世界のNADPHオキシダーゼ4市場：種類別市場規模予測 2021年-2026年（GKT-136901、GKT-831、MTfp-siRNA、その他） ・世界のNADPHオキシダーゼ4市場：用途別市場規模 2015年-2020年（虚血性脳卒中、腎臓病、肝線維症、腎臓線維症、その他） ・世界のNADPHオキシダーゼ4市場：用途別市場規模予測 2021年-2026年（虚血性脳卒中、腎臓病、肝線維症、腎臓線維症、その他） ・北米のNADPHオキシダーゼ4市場分析：米国、カナダ ・ヨーロッパのNADPHオキシダーゼ4市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのNADPHオキシダーゼ4市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のNADPHオキシダーゼ4市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのNADPHオキシダーゼ4市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bioasis Technologies Inc、GenKyoTex SA、Glucox Biotech AB ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global NADPH Oxidase 4 Market
The global NADPH Oxidase 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global NADPH Oxidase 4 Scope and Market Size
NADPH Oxidase 4 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NADPH Oxidase 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the NADPH Oxidase 4 market is segmented into
GKT-136901
GKT-831
MTfp-siRNA
Others
Segment by Application, the NADPH Oxidase 4 market is segmented into
Ischemic Stroke
Kidney Disease
Liver Fibrosis
Kindney Fibrosis
Others
Regional and Country-level Analysis
The NADPH Oxidase 4 market is analysed and market size information is provided by regions (countries).
The key regions covered in the NADPH Oxidase 4 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and NADPH Oxidase 4 Market Share Analysis
NADPH Oxidase 4 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in NADPH Oxidase 4 business, the date to enter into the NADPH Oxidase 4 market, NADPH Oxidase 4 product introduction, recent developments, etc.
The major vendors covered:
Bioasis Technologies Inc
GenKyoTex SA
Glucox Biotech AB
…
1 Study Coverage
1.1 NADPH Oxidase 4 Product Introduction
1.2 Market Segments
1.3 Key NADPH Oxidase 4 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global NADPH Oxidase 4 Market Size Growth Rate by Type
1.4.2 GKT-136901
1.4.3 GKT-831
1.4.4 MTfp-siRNA
1.4.5 Others
1.5 Market by Application
1.5.1 Global NADPH Oxidase 4 Market Size Growth Rate by Application
1.5.2 Ischemic Stroke
1.5.3 Kidney Disease
1.5.4 Liver Fibrosis
1.5.5 Kindney Fibrosis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global NADPH Oxidase 4 Market Size, Estimates and Forecasts
2.1.1 Global NADPH Oxidase 4 Revenue 2015-2026
2.1.2 Global NADPH Oxidase 4 Sales 2015-2026
2.2 Global NADPH Oxidase 4, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global NADPH Oxidase 4 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global NADPH Oxidase 4 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global NADPH Oxidase 4 Competitor Landscape by Players
3.1 NADPH Oxidase 4 Sales by Manufacturers
3.1.1 NADPH Oxidase 4 Sales by Manufacturers (2015-2020)
3.1.2 NADPH Oxidase 4 Sales Market Share by Manufacturers (2015-2020)
3.2 NADPH Oxidase 4 Revenue by Manufacturers
3.2.1 NADPH Oxidase 4 Revenue by Manufacturers (2015-2020)
3.2.2 NADPH Oxidase 4 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global NADPH Oxidase 4 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by NADPH Oxidase 4 Revenue in 2019
3.2.5 Global NADPH Oxidase 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 NADPH Oxidase 4 Price by Manufacturers
3.4 NADPH Oxidase 4 Manufacturing Base Distribution, Product Types
3.4.1 NADPH Oxidase 4 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers NADPH Oxidase 4 Product Type
3.4.3 Date of International Manufacturers Enter into NADPH Oxidase 4 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global NADPH Oxidase 4 Market Size by Type (2015-2020)
4.1.1 Global NADPH Oxidase 4 Sales by Type (2015-2020)
4.1.2 Global NADPH Oxidase 4 Revenue by Type (2015-2020)
4.1.3 NADPH Oxidase 4 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global NADPH Oxidase 4 Market Size Forecast by Type (2021-2026)
4.2.1 Global NADPH Oxidase 4 Sales Forecast by Type (2021-2026)
4.2.2 Global NADPH Oxidase 4 Revenue Forecast by Type (2021-2026)
4.2.3 NADPH Oxidase 4 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global NADPH Oxidase 4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global NADPH Oxidase 4 Market Size by Application (2015-2020)
5.1.1 Global NADPH Oxidase 4 Sales by Application (2015-2020)
5.1.2 Global NADPH Oxidase 4 Revenue by Application (2015-2020)
5.1.3 NADPH Oxidase 4 Price by Application (2015-2020)
5.2 NADPH Oxidase 4 Market Size Forecast by Application (2021-2026)
5.2.1 Global NADPH Oxidase 4 Sales Forecast by Application (2021-2026)
5.2.2 Global NADPH Oxidase 4 Revenue Forecast by Application (2021-2026)
5.2.3 Global NADPH Oxidase 4 Price Forecast by Application (2021-2026)
6 North America
6.1 North America NADPH Oxidase 4 by Country
6.1.1 North America NADPH Oxidase 4 Sales by Country
6.1.2 North America NADPH Oxidase 4 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America NADPH Oxidase 4 Market Facts & Figures by Type
6.3 North America NADPH Oxidase 4 Market Facts & Figures by Application
7 Europe
7.1 Europe NADPH Oxidase 4 by Country
7.1.1 Europe NADPH Oxidase 4 Sales by Country
7.1.2 Europe NADPH Oxidase 4 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe NADPH Oxidase 4 Market Facts & Figures by Type
7.3 Europe NADPH Oxidase 4 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific NADPH Oxidase 4 by Region
8.1.1 Asia Pacific NADPH Oxidase 4 Sales by Region
8.1.2 Asia Pacific NADPH Oxidase 4 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific NADPH Oxidase 4 Market Facts & Figures by Type
8.3 Asia Pacific NADPH Oxidase 4 Market Facts & Figures by Application
9 Latin America
9.1 Latin America NADPH Oxidase 4 by Country
9.1.1 Latin America NADPH Oxidase 4 Sales by Country
9.1.2 Latin America NADPH Oxidase 4 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America NADPH Oxidase 4 Market Facts & Figures by Type
9.3 Central & South America NADPH Oxidase 4 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa NADPH Oxidase 4 by Country
10.1.1 Middle East and Africa NADPH Oxidase 4 Sales by Country
10.1.2 Middle East and Africa NADPH Oxidase 4 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa NADPH Oxidase 4 Market Facts & Figures by Type
10.3 Middle East and Africa NADPH Oxidase 4 Market Facts & Figures by Application
11 Company Profiles
11.1 Bioasis Technologies Inc
11.1.1 Bioasis Technologies Inc Corporation Information
11.1.2 Bioasis Technologies Inc Description and Business Overview
11.1.3 Bioasis Technologies Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bioasis Technologies Inc NADPH Oxidase 4 Products Offered
11.1.5 Bioasis Technologies Inc Related Developments
11.2 GenKyoTex SA
11.2.1 GenKyoTex SA Corporation Information
11.2.2 GenKyoTex SA Description and Business Overview
11.2.3 GenKyoTex SA Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GenKyoTex SA NADPH Oxidase 4 Products Offered
11.2.5 GenKyoTex SA Related Developments
11.3 Glucox Biotech AB
11.3.1 Glucox Biotech AB Corporation Information
11.3.2 Glucox Biotech AB Description and Business Overview
11.3.3 Glucox Biotech AB Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Glucox Biotech AB NADPH Oxidase 4 Products Offered
11.3.5 Glucox Biotech AB Related Developments
11.1 Bioasis Technologies Inc
11.1.1 Bioasis Technologies Inc Corporation Information
11.1.2 Bioasis Technologies Inc Description and Business Overview
11.1.3 Bioasis Technologies Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bioasis Technologies Inc NADPH Oxidase 4 Products Offered
11.1.5 Bioasis Technologies Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 NADPH Oxidase 4 Market Estimates and Projections by Region
12.1.1 Global NADPH Oxidase 4 Sales Forecast by Regions 2021-2026
12.1.2 Global NADPH Oxidase 4 Revenue Forecast by Regions 2021-2026
12.2 North America NADPH Oxidase 4 Market Size Forecast (2021-2026)
12.2.1 North America: NADPH Oxidase 4 Sales Forecast (2021-2026)
12.2.2 North America: NADPH Oxidase 4 Revenue Forecast (2021-2026)
12.2.3 North America: NADPH Oxidase 4 Market Size Forecast by Country (2021-2026)
12.3 Europe NADPH Oxidase 4 Market Size Forecast (2021-2026)
12.3.1 Europe: NADPH Oxidase 4 Sales Forecast (2021-2026)
12.3.2 Europe: NADPH Oxidase 4 Revenue Forecast (2021-2026)
12.3.3 Europe: NADPH Oxidase 4 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific NADPH Oxidase 4 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: NADPH Oxidase 4 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: NADPH Oxidase 4 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: NADPH Oxidase 4 Market Size Forecast by Region (2021-2026)
12.5 Latin America NADPH Oxidase 4 Market Size Forecast (2021-2026)
12.5.1 Latin America: NADPH Oxidase 4 Sales Forecast (2021-2026)
12.5.2 Latin America: NADPH Oxidase 4 Revenue Forecast (2021-2026)
12.5.3 Latin America: NADPH Oxidase 4 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa NADPH Oxidase 4 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: NADPH Oxidase 4 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: NADPH Oxidase 4 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: NADPH Oxidase 4 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key NADPH Oxidase 4 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 NADPH Oxidase 4 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. NADPH Oxidase 4 Market Segments
Table 2. Ranking of Global Top NADPH Oxidase 4 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global NADPH Oxidase 4 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of GKT-136901
Table 5. Major Manufacturers of GKT-831
Table 6. Major Manufacturers of MTfp-siRNA
Table 7. Major Manufacturers of Others
Table 8. Global NADPH Oxidase 4 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global NADPH Oxidase 4 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global NADPH Oxidase 4 Sales by Regions 2015-2020 (K Pcs)
Table 11. Global NADPH Oxidase 4 Sales Market Share by Regions (2015-2020)
Table 12. Global NADPH Oxidase 4 Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global NADPH Oxidase 4 Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global NADPH Oxidase 4 Sales Share by Manufacturers (2015-2020)
Table 15. Global NADPH Oxidase 4 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global NADPH Oxidase 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NADPH Oxidase 4 as of 2019)
Table 17. NADPH Oxidase 4 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. NADPH Oxidase 4 Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers NADPH Oxidase 4 Price (2015-2020) (USD/Pcs)
Table 20. NADPH Oxidase 4 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers NADPH Oxidase 4 Product Type
Table 22. Date of International Manufacturers Enter into NADPH Oxidase 4 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global NADPH Oxidase 4 Sales by Type (2015-2020) (K Pcs)
Table 25. Global NADPH Oxidase 4 Sales Share by Type (2015-2020)
Table 26. Global NADPH Oxidase 4 Revenue by Type (2015-2020) (US$ Million)
Table 27. Global NADPH Oxidase 4 Revenue Share by Type (2015-2020)
Table 28. NADPH Oxidase 4 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global NADPH Oxidase 4 Sales by Application (2015-2020) (K Pcs)
Table 30. Global NADPH Oxidase 4 Sales Share by Application (2015-2020)
Table 31. North America NADPH Oxidase 4 Sales by Country (2015-2020) (K Pcs)
Table 32. North America NADPH Oxidase 4 Sales Market Share by Country (2015-2020)
Table 33. North America NADPH Oxidase 4 Revenue by Country (2015-2020) (US$ Million)
Table 34. North America NADPH Oxidase 4 Revenue Market Share by Country (2015-2020)
Table 35. North America NADPH Oxidase 4 Sales by Type (2015-2020) (K Pcs)
Table 36. North America NADPH Oxidase 4 Sales Market Share by Type (2015-2020)
Table 37. North America NADPH Oxidase 4 Sales by Application (2015-2020) (K Pcs)
Table 38. North America NADPH Oxidase 4 Sales Market Share by Application (2015-2020)
Table 39. Europe NADPH Oxidase 4 Sales by Country (2015-2020) (K Pcs)
Table 40. Europe NADPH Oxidase 4 Sales Market Share by Country (2015-2020)
Table 41. Europe NADPH Oxidase 4 Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe NADPH Oxidase 4 Revenue Market Share by Country (2015-2020)
Table 43. Europe NADPH Oxidase 4 Sales by Type (2015-2020) (K Pcs)
Table 44. Europe NADPH Oxidase 4 Sales Market Share by Type (2015-2020)
Table 45. Europe NADPH Oxidase 4 Sales by Application (2015-2020) (K Pcs)
Table 46. Europe NADPH Oxidase 4 Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific NADPH Oxidase 4 Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific NADPH Oxidase 4 Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific NADPH Oxidase 4 Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific NADPH Oxidase 4 Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific NADPH Oxidase 4 Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific NADPH Oxidase 4 Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific NADPH Oxidase 4 Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific NADPH Oxidase 4 Sales Market Share by Application (2015-2020)
Table 55. Latin America NADPH Oxidase 4 Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America NADPH Oxidase 4 Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa NADPH Oxidase 4 Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America NADPH Oxidase 4 Revenue Market Share by Country (2015-2020)
Table 59. Latin America NADPH Oxidase 4 Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America NADPH Oxidase 4 Sales Market Share by Type (2015-2020)
Table 61. Latin America NADPH Oxidase 4 Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America NADPH Oxidase 4 Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa NADPH Oxidase 4 Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa NADPH Oxidase 4 Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa NADPH Oxidase 4 Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa NADPH Oxidase 4 Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa NADPH Oxidase 4 Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa NADPH Oxidase 4 Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa NADPH Oxidase 4 Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa NADPH Oxidase 4 Sales Market Share by Application (2015-2020)
Table 71. Bioasis Technologies Inc Corporation Information
Table 72. Bioasis Technologies Inc Description and Major Businesses
Table 73. Bioasis Technologies Inc NADPH Oxidase 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Bioasis Technologies Inc Product
Table 75. Bioasis Technologies Inc Recent Development
Table 76. GenKyoTex SA Corporation Information
Table 77. GenKyoTex SA Description and Major Businesses
Table 78. GenKyoTex SA NADPH Oxidase 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. GenKyoTex SA Product
Table 80. GenKyoTex SA Recent Development
Table 81. Glucox Biotech AB Corporation Information
Table 82. Glucox Biotech AB Description and Major Businesses
Table 83. Glucox Biotech AB NADPH Oxidase 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Glucox Biotech AB Product
Table 85. Glucox Biotech AB Recent Development
Table 86. Global NADPH Oxidase 4 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 87. Global NADPH Oxidase 4 Sales Market Share Forecast by Regions (2021-2026)
Table 88. Global NADPH Oxidase 4 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 89. Global NADPH Oxidase 4 Revenue Market Share Forecast by Regions (2021-2026)
Table 90. North America: NADPH Oxidase 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 91. North America: NADPH Oxidase 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 92. Europe: NADPH Oxidase 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 93. Europe: NADPH Oxidase 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 94. Asia Pacific: NADPH Oxidase 4 Sales Forecast by Region (2021-2026) (K Pcs)
Table 95. Asia Pacific: NADPH Oxidase 4 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 96. Latin America: NADPH Oxidase 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 97. Latin America: NADPH Oxidase 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Middle East and Africa: NADPH Oxidase 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 99. Middle East and Africa: NADPH Oxidase 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 101. Key Challenges
Table 102. Market Risks
Table 103. Main Points Interviewed from Key NADPH Oxidase 4 Players
Table 104. NADPH Oxidase 4 Customers List
Table 105. NADPH Oxidase 4 Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. NADPH Oxidase 4 Product Picture
Figure 2. Global NADPH Oxidase 4 Sales Market Share by Type in 2020 & 2026
Figure 3. GKT-136901 Product Picture
Figure 4. GKT-831 Product Picture
Figure 5. MTfp-siRNA Product Picture
Figure 6. Others Product Picture
Figure 7. Global NADPH Oxidase 4 Sales Market Share by Application in 2020 & 2026
Figure 8. Ischemic Stroke
Figure 9. Kidney Disease
Figure 10. Liver Fibrosis
Figure 11. Kindney Fibrosis
Figure 12. Others
Figure 13. NADPH Oxidase 4 Report Years Considered
Figure 14. Global NADPH Oxidase 4 Market Size 2015-2026 (US$ Million)
Figure 15. Global NADPH Oxidase 4 Sales 2015-2026 (K Pcs)
Figure 16. Global NADPH Oxidase 4 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global NADPH Oxidase 4 Sales Market Share by Region (2015-2020)
Figure 18. Global NADPH Oxidase 4 Sales Market Share by Region in 2019
Figure 19. Global NADPH Oxidase 4 Revenue Market Share by Region (2015-2020)
Figure 20. Global NADPH Oxidase 4 Revenue Market Share by Region in 2019
Figure 21. Global NADPH Oxidase 4 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by NADPH Oxidase 4 Revenue in 2019
Figure 23. NADPH Oxidase 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global NADPH Oxidase 4 Sales Market Share by Type (2015-2020)
Figure 25. Global NADPH Oxidase 4 Sales Market Share by Type in 2019
Figure 26. Global NADPH Oxidase 4 Revenue Market Share by Type (2015-2020)
Figure 27. Global NADPH Oxidase 4 Revenue Market Share by Type in 2019
Figure 28. Global NADPH Oxidase 4 Market Share by Price Range (2015-2020)
Figure 29. Global NADPH Oxidase 4 Sales Market Share by Application (2015-2020)
Figure 30. Global NADPH Oxidase 4 Sales Market Share by Application in 2019
Figure 31. Global NADPH Oxidase 4 Revenue Market Share by Application (2015-2020)
Figure 32. Global NADPH Oxidase 4 Revenue Market Share by Application in 2019
Figure 33. North America NADPH Oxidase 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America NADPH Oxidase 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America NADPH Oxidase 4 Sales Market Share by Country in 2019
Figure 36. North America NADPH Oxidase 4 Revenue Market Share by Country in 2019
Figure 37. U.S. NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America NADPH Oxidase 4 Market Share by Type in 2019
Figure 42. North America NADPH Oxidase 4 Market Share by Application in 2019
Figure 43. Europe NADPH Oxidase 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe NADPH Oxidase 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe NADPH Oxidase 4 Sales Market Share by Country in 2019
Figure 46. Europe NADPH Oxidase 4 Revenue Market Share by Country in 2019
Figure 47. Germany NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe NADPH Oxidase 4 Market Share by Type in 2019
Figure 58. Europe NADPH Oxidase 4 Market Share by Application in 2019
Figure 59. Asia Pacific NADPH Oxidase 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific NADPH Oxidase 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific NADPH Oxidase 4 Sales Market Share by Region in 2019
Figure 62. Asia Pacific NADPH Oxidase 4 Revenue Market Share by Region in 2019
Figure 63. China NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific NADPH Oxidase 4 Market Share by Type in 2019
Figure 86. Asia Pacific NADPH Oxidase 4 Market Share by Application in 2019
Figure 87. Latin America NADPH Oxidase 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America NADPH Oxidase 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America NADPH Oxidase 4 Sales Market Share by Country in 2019
Figure 90. Latin America NADPH Oxidase 4 Revenue Market Share by Country in 2019
Figure 91. Mexico NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America NADPH Oxidase 4 Market Share by Type in 2019
Figure 98. Latin America NADPH Oxidase 4 Market Share by Application in 2019
Figure 99. Middle East and Africa NADPH Oxidase 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa NADPH Oxidase 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa NADPH Oxidase 4 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa NADPH Oxidase 4 Revenue Market Share by Country in 2019
Figure 103. Turkey NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E NADPH Oxidase 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E NADPH Oxidase 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa NADPH Oxidase 4 Market Share by Type in 2019
Figure 110. Middle East and Africa NADPH Oxidase 4 Market Share by Application in 2019
Figure 111. North America NADPH Oxidase 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America NADPH Oxidase 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe NADPH Oxidase 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe NADPH Oxidase 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific NADPH Oxidase 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific NADPH Oxidase 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America NADPH Oxidase 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America NADPH Oxidase 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa NADPH Oxidase 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa NADPH Oxidase 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
嚢胞性線維症（ムコビスコイドーシス）検査の世界市場（～2026年） Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thi…- 急性虚血性脳卒中治療薬の世界市場（～2026年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…
- 虚血性脳卒中治療薬の世界市場（～2026年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Asia Pacific is anticipated to unfold as the mo…
- 特発性肺線維症（IPF）の世界市場（～2026年） Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen. An increase in the incidence and prevalence of fibrotic diseases is the primary driver…
- 虚血性脳卒中予防治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ischemic Cerebral Stroke Prevention Therapeutics Market The global Ischemic Cerebral Stroke Prevention Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ischemic Cerebral…